Development Level

Tbio 4 | 10,625
Tchem 2 | 1,890

IMPC Term

abnormal behavior 1 | 226
decreased grip strength 1 | 123
decreased vertical activity 1 | 22
hypoactivity 1 | 89

Disease

Obesity 6 | 616
Cancer 5 | 2,346
Hypertension 5 | 287
diabetes mellitus 5 | 1,663
Alzheimer's disease 4 | 644
Cocaine-Related Disorders 4 | 88
Eating disorder 4 | 24
Hyperglycemia 4 | 120
Hyperinsulinism 4 | 63
Metabolic syndrome X 4 | 155
Prader-Willi syndrome 4 | 45
Schizophrenia 4 | 501
Seizures 4 | 95
Alcohol dependence 3 | 107
Amenorrhea 3 | 60
Arthritis 3 | 248
Asthma 3 | 349
Atherosclerosis 3 | 275
Cerebrovascular disease 3 | 231
Heart disease 3 | 279
Hyperthyroidism 3 | 50
Hypoglycemia 3 | 81
Osteoporosis 3 | 257
Polycystic Ovary Syndrome 3 | 332
psoriasis 3 | 6,685
Acanthosis nigricans 2 | 14
Allergic hypersensitivity disease 2 | 123
Anorexia nervosa 2 | 59
Anovulation 2 | 20
Anxiety Disorders 2 | 37
Autistic Disorder 2 | 320
Autonomic neuropathy 2 | 21
Brain disease 2 | 83
Bulimia nervosa 2 | 15
Coronary artery disease 2 | 240
Dementia 2 | 129
Depressive disorder 2 | 48
Diabetes Mellitus, Non-Insulin-Dependent 2 | 157
Epilepsy 2 | 346
Fatty Liver 2 | 48
Fatty liver disease 2 | 84
Gastric ulcer 2 | 34
Gastroparesis 2 | 20
Heart failure 2 | 80
Hepatitis C 2 | 90
Huntington's disease 2 | 72
Hyperactive behavior 2 | 31
Hyperandrogenism 2 | 32
Hypertensive disease 2 | 193
Hypogonadism 2 | 70
Hypothyroidism 2 | 89
Infertility 2 | 163
Insulin Resistance 2 | 48
Kidney disease 2 | 396
Kidney failure 2 | 39
Lipid metabolism disorder 2 | 102
Lipodystrophy 2 | 32
Liver disease 2 | 219
Major Depressive Disorder 2 | 106
Memory Disorders 2 | 36
Migraine 2 | 79
Narcolepsy 2 | 58
Nerve Degeneration 2 | 73
Neural Tube Defects 2 | 27
Neuropathy 2 | 210
Obstructive sleep apnea 2 | 28
Prostatic Neoplasms 2 | 471
Rhinitis 2 | 46
Substance Withdrawal Syndrome 2 | 52
Tachycardia 2 | 17
Weight Gain 2 | 87
Weight decreased 2 | 18
intraductal papillary-mucinous carcinoma (IPMC) 2 | 2,988
intraductal papillary-mucinous neoplasm (IPMN) 2 | 3,289
Anorexia 1 | 15
Arthritis, Experimental 1 | 39
Bronchitis, Chronic 1 | 9
Complex regional pain syndrome 1 | 12
Diabetic Nephropathy 1 | 37
Diabetic Retinopathy 1 | 53
Diarrhea 1 | 155
Dumping syndrome 1 | 9
Duodenal ulcer 1 | 20
Exocrine pancreatic insufficiency 1 | 21
Gastritis 1 | 44
Gastrointestinal system disease 1 | 50
Gestational Diabetes 1 | 17
Hypertriglyceridemia 1 | 18
Hypokalemia 1 | 40
Hypotension 1 | 53
Mood disorder 1 | 10
Muscle Rigidity 1 | 5
Pain 1 | 70
Pancreatitis 1 | 97
Periodontal disease 1 | 37
Restless legs syndrome 1 | 28
Type 1 diabetes mellitus 1 | 101
Ventricular Dysfunction, Left 1 | 15
Wolfram syndrome 1 | 11
maturity-onset diabetes of the young 1 | 28

Tissue

Endocrine System 6 | 18,512
Female tissues 6 | 18,647
Nervous System 6 | 18,561
Blood and immune system 5 | 17,995
Cardiovascular System 5 | 17,958
Digestive Tract 5 | 18,473
Liver and Pancreas 5 | 18,136
Male tissues 5 | 17,969
Skin and soft tissues 5 | 18,115
Urinary Tract 5 | 18,444
Respiratory system 3 | 17,484

Target Family

Non-IDG 6 | 11,971

Grant Application

3R15DC007389-02S1 6 | 6
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Pro-neuropeptide Y NPY Tbio Non-IDG -3.81741 7285.3 401
Insulin INS Tbio Non-IDG -5.14691 141255.4 1549
Orexin HCRT Tbio Non-IDG -3.27026 2104.5 162
Neuropeptide S NPS Tchem Non-IDG -3.89942 7090.5 86
Appetite-regulating hormone GHRL Tchem Non-IDG -3.59108 4732.2 532
Leptin LEP Tbio Non-IDG -4.13745 15277.2 796